{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:12:56Z","timestamp":1790946776667,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007083","name":"Orion Research Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015738","name":"Mary and Georg C Ehrnrooth Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Childhood Disease Research Fundation","doi-asserted-by":"publisher","award":["250288"],"award-info":[{"award-number":["250288"]}],"id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Childhood Disease Research Fundation","doi-asserted-by":"publisher","award":["240050"],"award-info":[{"award-number":["240050"]}],"id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.dld.2026.06.001","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:23:08Z","timestamp":1781954588000},"page":"1043-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proximally dominant inflammation at colonoscopy predicts pan-colonic histological remission following oral vancomycin therapy in pediatric ulcerative colitis"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4892-5710","authenticated-orcid":false,"given":"Laura","family":"R\u00e4is\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariha","family":"Balouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lewindon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dld.2026.06.001_bib0001","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ibd.23013","article-title":"Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS registry","volume":"19","author":"Levine","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.dld.2026.06.001_bib0002","first-page":"1078","article-title":"Development and validation of diagnostic criteria for IBD subtypes including IBD-unclassified in children: a multicentre study from the pediatric IBD porto group of ESPGHAN","volume":"11","author":"Birimberg-Schwartz","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.dld.2026.06.001_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.dld.2026.06.001_bib0004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"issue":"24","key":"10.1016\/j.dld.2026.06.001_bib0005","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.dld.2026.06.001_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112877","article-title":"PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)","volume":"9","author":"Stinton","year":"2014","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.dld.2026.06.001_bib0007","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: a review","volume":"26","author":"Little","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"25","key":"10.1016\/j.dld.2026.06.001_bib0008","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.dld.2026.06.001_bib0009","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cgh.2018.01.020","article-title":"Symptoms do not correlate with findings from colonoscopy in children with inflammatory bowel disease and primary sclerosing cholangitis","volume":"16","author":"Ricciuto","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2026.06.001_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"Van Munster","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.06.001_bib0011","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00428-025-04072-y","article-title":"Unique clinical, morphological, and molecular characteristics of tumors associated with PSC-IBD","volume":"486","author":"Vajsova","year":"2025","journal-title":"Virchows Arch"},{"issue":"10207","key":"10.1016\/j.dld.2026.06.001_bib0012","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dld.2026.06.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001605","article-title":"Outcomes of oral vancomycin therapy in children with atypical ulcerative colitis with or without confirmed primary sclerosing cholangitis: a real-world observational study","volume":"12","author":"R\u00e4is\u00e4nen","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2026.06.001_bib0014","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/HEP.0000000000000926","article-title":"Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury","volume":"82","author":"Kellermayer","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2026.06.001_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4254\/wjh.v11.i1.19","article-title":"Treatment of primary sclerosing cholangitis in children","volume":"11","author":"Laborda","year":"2019","journal-title":"World J Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2026.06.001_bib0016","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/apt.17936","article-title":"Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): a matched analysis from the Paediatric PSC Consortium","volume":"59","author":"Ricciuto","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.dld.2026.06.001_bib0017","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"10.1016\/j.dld.2026.06.001_bib0018","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.dld.2026.06.001_bib0019","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification","volume":"17","author":"Levine","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.dld.2026.06.001_bib0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2026.06.001_bib0021","doi-asserted-by":"crossref","first-page":"G1266","DOI":"10.1152\/ajpgi.00357.2010","article-title":"Regional differences in colonic mucosa-associated microbiota determine the physiological expression of host heat shock proteins","volume":"299","author":"Hu","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.dld.2026.06.001_bib0022","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/bcp.70200","article-title":"Reconsidering the microbial origins of primary sclerosing cholangitis and related autoimmune disorders: a case for the antro-duodenal microbiome","volume":"91","author":"Kellermayer","year":"2025","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.dld.2026.06.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae189","article-title":"Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host\u2013Microbiome\u2013Metabolomic signatures","volume":"19","author":"Quraishi","year":"2025","journal-title":"J Crohns Colitis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582600753X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582600753X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:25:07Z","timestamp":1785882307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582600753X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S159086582600753X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.06.001","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proximally dominant inflammation at colonoscopy predicts pan-colonic histological remission following oral vancomycin therapy in pediatric ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}